Pharma

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Most Viewed Abstracts



Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Teva Pharmaceutical Industries Ltd. announced today that Israel Makov, 67, has announced his plans to retire as President and CEO during the course of 2007. Shlomo Yanai, 55, will join the company as President and CEO Designate during the first part of 2007. Mr. Makov will continue to work with Teva as a senior strategic advisor to the company for the next two years and, during the transition period, Messrs. Makov and Yanai, along with the board, will work together to ensure a seamless leadership transition

Today in Execs on the Move...keeping you current

Boston Scientific Announces Election of Nelda Connors to Its Board of Directors
Boston Scientific, 12/17/09

Sanofi-aventis Board of Directors of December 2009
Sanofi-aventis, 12/17/09

Bristol-Myers Squibb Announces Appointment of Charles Bancroft as Acting Chief Financial Officer
Bristol Myers-Squibb Company, 12/15/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address